Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Argentina Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20053
20062
20073
20081
20093
20101
20124
20133
20141
20181
20193
20216
20227
20231
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting14
Recruiting7
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
Eli Lilly and Company6
Novartis Pharmaceuticals6
Pfizer5
Sanofi4
Bristol-Myers Squibb2
Celcuity Inc2
Hoffmann-La Roche2
AbbVie1
Alaunos Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis51
Breast Neoplasms19
Carcinoma, Non-Small-Cell Lung7
Neoplasms7
Carcinoma5
Carcinoma, Renal Cell4
Colorectal Neoplasms4
Melanoma4
Skin Neoplasms3
Bone Neoplasms2

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.